Merck EPS beats by $0.32, beats on revenue

Merck (NYSE:MRK): Q2 Non-GAAP EPS of $1.37 beats by $0.32; GAAP EPS of $1.18 beats by $0.27.

Revenue of $10.87B (-7.6% Y/Y) beats by $350M.

Keytruda revenues of $3.39B vs. consensus of $3.13B.

Januvia/Janumet sales of $1.34B vs. estimate of $1.26B.

Shares +1.41% PM.

Press Release

https://seekingalpha.com/news/3598276-merck-eps-beats-0_32-beats-on-revenue